Source: www.businesswire.com Author: press release The Human Papillomavirus (HPV) is the causative agent responsible for most cases of cervical cancer, but is also associated with several other types of cancer. Expert physicians from the National Comprehensive Cancer Network (NCCN) Member Institutions presented an update on HPV and its link to various cancers including cervical cancer, anal carcinoma, [...]
Continue reading...Tuesday, March 9, 2010
Source: pharmalive.com/News Author: press release BT Pharma, a biopharmaceutical company developing innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today that it has raised EUR 13.1 million in additional funding and changed its name to Genticel. AGF Private Equity led the round, which brought in three new investors, IRDI (Institut Régional de Développement [...]
Continue reading...Thursday, February 11, 2010
Source: www.ctv.ca Author: staff Canadian women have a choice of two vaccines against HPV, the family of viruses that can cause cervical cancer, now that Health Canada has approved GlaxoSmithKline’s vaccine, Cervarix. The vaccine, which is expected to be available by the end of the month, will compete against Gardasil, a product of Merck Canada, which has been [...]
Continue reading...Saturday, January 9, 2010
Source: www.huffingtonpost.com Author: Marcia G. Yerman As parents contemplate whether or not they should have the Gardasil vaccine administered to their daughters, one of the first places that they turn is to their doctors. In this segment, I posed questions to two doctors supporting the vaccine. Dr. Margaret Lewin, M.D., F.A.C.P., is the Medical Director of Cinergy Health, [...]
Continue reading...Monday, January 4, 2010
Source: www.liverpoolecho.co.uk Author: Liza Williams ONE central project the scientists and doctors are working on is a vaccine for mouth cancer. Liverpool researchers have found some cases are caused by the HPV virus – the same bug which causes cervical cancer. They have discovered that two-thirds of tonsil cancer tumour samples showed evidence of the HPV-16 [...]
Continue reading...Monday, December 7, 2009
Source: professional.cancerconsultants.com Author: staff Researchers affiliated with the GlaxoSmithKline Vaccine HPV-007 Study Group have reported that Cervarix® [human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine] has “high and sustained immunogenicity, and a favorable safety” profile for up to 6.4 years following administration. The details of this study appeared in an early online publication in the Lancet on December 3, 2009.[1] Cervarix [...]
Continue reading...Tuesday, December 1, 2009
Source: news.biocompare.com Authors: David J. Mooney et al. A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal Science Translational Medicine. The new approach, pioneered by bioengineers and immunologists at Harvard University, uses plastic disks impregnated with tumor-specific antigens [...]
Continue reading...Saturday, November 28, 2009
Source: www.nbc-2.com Author: staff TAMPA: David Hastings is back to helping his wife Jo at their Cuban restaurant outside Saint Petersburg. He’s grateful to be here after a very close call. “One morning I was shaving and I noticed this side of my neck was swollen,” Hastings explained. The diagnosis: stage four oral cancer. Until then, David was a [...]
Continue reading...Saturday, November 28, 2009
Source: www.acorn-online.com Author: Susan Wolf Colleen Zenk Pinter of Redding, an actor who stars as Barbara Ryan on As the World Turns, has partnered with the Oral Cancer Foundation, Yale New-Haven Hospital and Roswell Park Cancer Institute to be a spokesperson for oral cancer. Ms. Pinter was diagnosed with oral cancer in March 2007 and is [...]
Continue reading...Tuesday, November 10, 2009
Source: www.newswise.com Author: staff Breakthrough study reports complete and partial remissions following vaccination A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine. According to a report published in the November 5 [...]
Continue reading...
Thursday, March 11, 2010
0 Comments